Compare Cohen & Steers, Inc. (New York) with Similar Stocks
Dashboard
1
Strong Long Term Fundamental Strength with an average Return on Equity (ROE) of 49.79%
2
Poor long term growth as Net Sales has grown by an annual rate of 5.44% and Operating profit at 9.47%
3
Flat results in Jun 25
4
With ROE of 30.93%, it has a expensive valuation with a 8.56 Price to Book Value
5
Below par performance in long term as well as near term
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-1.29%
0%
-1.29%
6 Months
-10.58%
0%
-10.58%
1 Year
-21.27%
0%
-21.27%
2 Years
-11.85%
0%
-11.85%
3 Years
-1.75%
0%
-1.75%
4 Years
-24.92%
0%
-24.92%
5 Years
-4.01%
0%
-4.01%
Cohen & Steers, Inc. (New York) for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
5.64%
EBIT Growth (5y)
16.99%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
20.96%
Dividend Payout Ratio
83.50%
Pledged Shares
0
Institutional Holding
58.58%
ROCE (avg)
96.66%
ROE (avg)
49.79%
Valuation key factors
Factor
Value
P/E Ratio
24
Industry P/E
Price to Book Value
6.46
EV to EBIT
19.47
EV to EBITDA
18.50
EV to Capital Employed
6.46
EV to Sales
6.54
PEG Ratio
23.70
Dividend Yield
3.55%
ROCE (Latest)
33.18%
ROE (Latest)
27.26%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
Bullish
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bearish
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 65 Schemes (31.21%)
Foreign Institutions
Held by 96 Foreign Institutions (4.18%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
Dec'25
Sep'25
Change(%)
Net Sales
157.80
141.70
11.36%
Operating Profit (PBDIT) excl Other Income
40.60
52.10
-22.07%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
30.70
41.60
-26.20%
Operating Profit Margin (Excl OI)
241.30%
350.00%
-10.87%
USD in Million.
Net Sales
QoQ Growth in quarter ended Dec 2025 is 11.36% vs 3.89% in Sep 2025
Consolidated Net Profit
QoQ Growth in quarter ended Dec 2025 is -26.20% vs -0.48% in Sep 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
571.50
514.20
11.14%
Operating Profit (PBDIT) excl Other Income
195.90
196.20
-0.15%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
157.40
162.80
-3.32%
Operating Profit Margin (Excl OI)
325.70%
363.50%
-3.78%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 11.14% vs 6.33% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -3.32% vs 19.18% in Dec 2024
About Cohen & Steers, Inc. (New York) 
Cohen & Steers, Inc. (New York)
Capital Markets
Cohen & Steers, Inc. (CNS) is a holding company. The Company is an investment manager with a focus on liquid real assets, including real estate securities, listed infrastructure, commodities and natural resource equities, as well as preferred securities and other income solutions. The Company serves institutional and individual investors. The Company manages three types of investment vehicles: institutional accounts, open-end funds and closed-end funds. The Company also provides services in connection with model-based strategies (MBS) accounts. In addition, the Company provides several services in connection with assets held by unit investment trusts (UITs). As a portfolio consultant to a number of UITs, the Company constructs a portfolio of securities that suit the investment objective of the UIT. The Company also provides ongoing portfolio monitoring services and provides a license to certain firms to use its name in connection with certain of their investment products.
Company Coordinates 
Company Details
280 Park Ave Fl 10 , NEW YORK NY : 10017-1220
Registrar Details






